Wire · opportunities
Spatial biomarker to companion diagnostic
◆ Sectors
Diagnostics
◆ Source
◆ Verified
Fusion42 · 19 August 2026 · Fusion42 review
The article details the development path of spatial biomarkers into companion diagnostics, emphasizing the importance of assay standardization, analytical and clinical validation, and multi-site reproducibility for reliable clinical use.
This Wire brief sits within Fusion42's coverage of Diagnostics.
◆ ◆ The Wire takeaway
You now need to fix and thoroughly validate your assay parameters to move beyond research into clinical diagnostics reliably. This means locking down your protocol early to avoid costly setbacks and proving reproducibility across different labs.
◆ Coverage
1 source · 19 Aug 2026
◆ Related on Wire
◆ Topics
Diagnosticsspatial-biomarkercompanion-diagnosticassay-validationclinical-trialsreproducibility